These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 22927827)

  • 1. SEMA3A, a gene involved in axonal pathfinding, is mutated in patients with Kallmann syndrome.
    Hanchate NK; Giacobini P; Lhuillier P; Parkash J; Espy C; Fouveaut C; Leroy C; Baron S; Campagne C; Vanacker C; Collier F; Cruaud C; Meyer V; García-Piñero A; Dewailly D; Cortet-Rudelli C; Gersak K; Metz C; Chabrier G; Pugeat M; Young J; Hardelin JP; Prevot V; Dodé C
    PLoS Genet; 2012 Aug; 8(8):e1002896. PubMed ID: 22927827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective signaling through plexin-A1 compromises the development of the peripheral olfactory system and neuroendocrine reproductive axis in mice.
    Marcos S; Monnier C; Rovira X; Fouveaut C; Pitteloud N; Ango F; Dodé C; Hardelin JP
    Hum Mol Genet; 2017 Jun; 26(11):2006-2017. PubMed ID: 28334861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective gonadotropin-releasing hormone neuron migration in mice lacking SEMA3A signalling through NRP1 and NRP2: implications for the aetiology of hypogonadotropic hypogonadism.
    Cariboni A; Davidson K; Rakic S; Maggi R; Parnavelas JG; Ruhrberg C
    Hum Mol Genet; 2011 Jan; 20(2):336-44. PubMed ID: 21059704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SEMA3A deletion in a family with Kallmann syndrome validates the role of semaphorin 3A in human puberty and olfactory system development.
    Young J; Metay C; Bouligand J; Tou B; Francou B; Maione L; Tosca L; Sarfati J; Brioude F; Esteva B; Briand-Suleau A; Brisset S; Goossens M; Tachdjian G; Guiochon-Mantel A
    Hum Reprod; 2012 May; 27(5):1460-5. PubMed ID: 22416012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation screening of SEMA3A and SEMA7A in patients with congenital hypogonadotropic hypogonadism.
    Känsäkoski J; Fagerholm R; Laitinen EM; Vaaralahti K; Hackman P; Pitteloud N; Raivio T; Tommiska J
    Pediatr Res; 2014 May; 75(5):641-4. PubMed ID: 24522099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective AMH signaling disrupts GnRH neuron development and function and contributes to hypogonadotropic hypogonadism.
    Malone SA; Papadakis GE; Messina A; Mimouni NEH; Trova S; Imbernon M; Allet C; Cimino I; Acierno J; Cassatella D; Xu C; Quinton R; Szinnai G; Pigny P; Alonso-Cotchico L; Masgrau L; Maréchal JD; Prevot V; Pitteloud N; Giacobini P
    Elife; 2019 Jul; 8():. PubMed ID: 31291191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain endothelial cells control fertility through ovarian-steroid-dependent release of semaphorin 3A.
    Giacobini P; Parkash J; Campagne C; Messina A; Casoni F; Vanacker C; Langlet F; Hobo B; Cagnoni G; Gallet S; Hanchate NK; Mazur D; Taniguchi M; Mazzone M; Verhaagen J; Ciofi P; Bouret SG; Tamagnone L; Prevot V
    PLoS Biol; 2014 Mar; 12(3):e1001808. PubMed ID: 24618750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PLXNA1 and PLXNA3 cooperate to pattern the nasal axons that guide gonadotropin-releasing hormone neurons.
    Oleari R; Caramello A; Campinoti S; Lettieri A; Ioannou E; Paganoni A; Fantin A; Cariboni A; Ruhrberg C
    Development; 2019 Nov; 146(21):. PubMed ID: 31690636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional analysis of SEMA3A variants identified in Chinese patients with isolated hypogonadotropic hypogonadism.
    Dai W; Li JD; Zhao Y; Wu J; Jiang F; Chen DN; Zheng R; Men M
    Clin Genet; 2020 May; 97(5):696-703. PubMed ID: 32060892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital Hypogonadotropic Hypogonadism with Anosmia and Gorlin Features Caused by a PTCH1 Mutation Reveals a New Candidate Gene for Kallmann Syndrome.
    Barraud S; Delemer B; Poirsier-Violle C; Bouligand J; Mérol JC; Grange F; Higel-Chaufour B; Decoudier B; Zalzali M; Dwyer AA; Acierno JS; Pitteloud N; Millar RP; Young J
    Neuroendocrinology; 2021; 111(1-2):99-114. PubMed ID: 32074614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sema3a plays a role in the pathogenesis of CHARGE syndrome.
    Ufartes R; Schwenty-Lara J; Freese L; Neuhofer C; Möller J; Wehner P; van Ravenswaaij-Arts CMA; Wong MTY; Schanze I; Tzschach A; Bartsch O; Borchers A; Pauli S
    Hum Mol Genet; 2018 Apr; 27(8):1343-1352. PubMed ID: 29432577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The product of X-linked Kallmann's syndrome gene (KAL1) affects the migratory activity of gonadotropin-releasing hormone (GnRH)-producing neurons.
    Cariboni A; Pimpinelli F; Colamarino S; Zaninetti R; Piccolella M; Rumio C; Piva F; Rugarli EI; Maggi R
    Hum Mol Genet; 2004 Nov; 13(22):2781-91. PubMed ID: 15471890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semaphorin 3A-Neuropilin-1 signaling regulates peripheral axon fasciculation and pathfinding but not developmental cell death patterns.
    Haupt C; Kloos K; Faus-Kessler T; Huber AB
    Eur J Neurosci; 2010 Apr; 31(7):1164-72. PubMed ID: 20345923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Neuropilin-1/Semaphorin-3A signaling in the functional and morphological integrity of the cochlea.
    Salehi P; Ge MX; Gundimeda U; Michelle Baum L; Lael Cantu H; Lavinsky J; Tao L; Myint A; Cruz C; Wang J; Nikolakopoulou AM; Abdala C; Kelley MW; Ohyama T; Coate TM; Friedman RA
    PLoS Genet; 2017 Oct; 13(10):e1007048. PubMed ID: 29059194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FGFR1 mutations in Kallmann syndrome.
    Villanueva C; de Roux N
    Front Horm Res; 2010; 39():51-61. PubMed ID: 20389085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further delineation of a recognizable type of syndromic short stature caused by biallelic SEMA3A loss-of-function variants.
    Gileta AF; Helgeson ML; Leonard JMM; Pyle LC; Subramanian HP; Arndt K; Hawkes CP; Del Gaudio D
    Am J Med Genet A; 2021 Mar; 185(3):889-893. PubMed ID: 33369061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of autosomal genes in Kallmann syndrome: genotype-phenotype correlations and neuroendocrine characteristics.
    Oliveira LM; Seminara SB; Beranova M; Hayes FJ; Valkenburgh SB; Schipani E; Costa EM; Latronico AC; Crowley WF; Vallejo M
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1532-8. PubMed ID: 11297579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism.
    Pitteloud N; Zhang C; Pignatelli D; Li JD; Raivio T; Cole LW; Plummer L; Jacobson-Dickman EE; Mellon PL; Zhou QY; Crowley WF
    Proc Natl Acad Sci U S A; 2007 Oct; 104(44):17447-52. PubMed ID: 17959774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PROK2/PROKR2 Signaling and Kallmann Syndrome.
    Dodé C; Rondard P
    Front Endocrinol (Lausanne); 2013; 4():19. PubMed ID: 23596439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semaphorin 3A-mediated axon guidance regulates convergence and targeting of P2 odorant receptor axons.
    Schwarting GA; Raitcheva D; Crandall JE; Burkhardt C; Püschel AW
    Eur J Neurosci; 2004 Apr; 19(7):1800-10. PubMed ID: 15078553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.